Trial Profile
A study investigating the effect of sorafenib and association of Japan Red Cross score with prognosis of sorafenib in patients with hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 25 Nov 2015 New trial record
- 01 Oct 2015 Results published in the Hepatology Research